{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T14:30:02Z","timestamp":1781965802242,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,30]]},"DOI":"10.7759\/cureus.89063","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:01Z","timestamp":1753890901000},"source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic Performance of CSF Interleukin-10 in Primary Central Nervous System Lymphoma: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Eliezer","family":"Villanueva-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Guillermo","family":"Flores-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Hern\u00e1ndez Res\u00e9ndiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A","family":"Rodr\u00edguez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Abdiel","family":"Rodr\u00edguez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Villalobos-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Moncada-Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Mu\u00f1uzuri-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo de Jes\u00fas","family":"Mateo-Nouel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Wong-Achi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Alberto","family":"Palacios-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Cacho-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo Axayacalt","family":"Gutierrez-Aceves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Moreno-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gonz\u00e1lez-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10851","article-title":"The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis","volume":"95","author":"Olson JE","year":"2002","unstructured":"Olson JE, Janney CA, Rao RD, et al.. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer. 2002, 95:1504-10. 10.1002\/cncr.10851","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq010","article-title":"Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma","volume":"12","author":"Pels H","year":"2010","unstructured":"Pels H, Juergens A, Schirgens I, et al.. Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma. Neuro Oncol. 2010, 12:720-4. 10.1093\/neuonc\/noq010","journal-title":"Neuro Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2021.09.004","article-title":"Primary central nervous system lymphomas","volume":"36","author":"Chukwueke U","year":"2022","unstructured":"Chukwueke U, Grommes C, Nayak L. Primary central nervous system lymphomas. Hematol Oncol Clin North Am. 2022, 36:147-59. 10.1016\/j.hoc.2021.09.004","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2660","article-title":"18F-FDG PET of common enhancing malignant brain tumors","volume":"190","author":"Kosaka N","year":"2008","unstructured":"Kosaka N, Tsuchida T, Uematsu H, Kimura H, Okazawa H, Itoh H. 18F-FDG PET of common enhancing malignant brain tumors. AJR Am J Roentgenol. 2008, 190:W365-9. 10.2214\/AJR.07.2660","journal-title":"AJR Am J Roentgenol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-012-1089-6","article-title":"Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and \u00b9\u2078F-fluorodeoxyglucose positron emission tomography","volume":"55","author":"Yamashita K","year":"2013","unstructured":"Yamashita K, Yoshiura T, Hiwatashi A, et al.. Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and \u00b9\u2078F-fluorodeoxyglucose positron emission tomography. Neuroradiology. 2013, 55:135-43. 10.1007\/s00234-012-1089-6","journal-title":"Neuroradiology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.606","article-title":"A systematic approach to the diagnosis of suspected central nervous system lymphoma","volume":"70","author":"Scott BJ","year":"2013","unstructured":"Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol. 2013, 70:311-19. 10.1001\/jamaneurol.2013.606","journal-title":"JAMA Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-0031","article-title":"IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma","volume":"48","author":"Cassoux N","year":"2007","unstructured":"Cassoux N, Giron A, Bodaghi B, et al.. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci. 2007, 48:3253-9. 10.1167\/iovs.06-0031","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-020-02377-0","article-title":"Atypical radiological findings of primary central nervous system lymphoma","volume":"62","author":"Lin X","year":"2020","unstructured":"Lin X, Khan IR, Seet YH, Lee HY, Yu WY. Atypical radiological findings of primary central nervous system lymphoma. Neuroradiology. 2020, 62:669-76. 10.1007\/s00234-020-02377-0","journal-title":"Neuroradiology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1076\/ocii.8.4.243.6463","article-title":"Ocular and central nervous system lymphoma: clinical features and diagnosis","volume":"8","author":"Cassoux N","year":"2000","unstructured":"Cassoux N, Merle-Beral H, Leblond V, et al.. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm. 2000, 8:243-50. 10.1076\/ocii.8.4.243.6463","journal-title":"Ocul Immunol Inflamm"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-012-0150-7","article-title":"Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma","volume":"56","author":"Kimura K","year":"2012","unstructured":"Kimura K, Usui Y, Goto H. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol. 2012, 56:383-9. 10.1007\/s10384-012-0150-7","journal-title":"Jpn J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00811-X","article-title":"Vitreous cytokine levels","volume":"110","author":"Wolf LA","year":"2003","unstructured":"Wolf LA, Reed GF, Buggage RR, Nussenblatt RB, Chan CC. Vitreous cytokine levels. Ophthalmology. 2003, 110:1671-2. 10.1016\/S0161-6420(03)00811-X","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000449","article-title":"Central nervous system lymphoma: approach to diagnosis and treatment","volume":"26","author":"Correia CE","year":"2020","unstructured":"Correia CE, Schaff LR, Grommes C. Central nervous system lymphoma: approach to diagnosis and treatment. Cancer J. 2020, 26:241-52. 10.1097\/PPO.0000000000000449","journal-title":"Cancer J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200212000-00012","article-title":"Intraocular lymphoma","volume":"13","author":"Chan CC","year":"2002","unstructured":"Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol. 2002, 13:411-18. 10.1097\/00055735-200212000-00012","journal-title":"Curr Opin Ophthalmol"},{"key":"ref14","article-title":"Molecular pathology of primary intraocular lymphoma","volume":"101","author":"Chan CC","year":"2003","unstructured":"Chan CC. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc. 2003, 101:275-92.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nor203","article-title":"Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)","volume":"14","author":"Sasayama T","year":"2012","unstructured":"Sasayama T, Nakamizo S, Nishihara M, et al.. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL). Neuro Oncol. 2012, 14:368-80. 10.1093\/neuonc\/nor203","journal-title":"Neuro Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17357","article-title":"MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study","volume":"193","author":"Ferreri AJ","year":"2021","unstructured":"Ferreri AJ, Calimeri T, Lopedote P, et al.. MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study. Br J Haematol. 2021, 193:497-505. 10.1111\/bjh.17357","journal-title":"Br J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-476333","article-title":"CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma","volume":"121","author":"Rubenstein JL","year":"2013","unstructured":"Rubenstein JL, Wong VS, Kadoch C, et al.. CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma. Blood. 2013, 121:4740-8. 10.1182\/blood-2013-01-476333","journal-title":"Blood"},{"key":"ref18","article-title":"Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade","volume":"25","author":"Law M","year":"2004","unstructured":"Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, Johnson G. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol. 2004, 25:746-55.","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s003300101037","article-title":"Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients","volume":"12","author":"Coulon A","year":"2002","unstructured":"Coulon A, Lafitte F, Hoang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J, Chiras J. Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol. 2002, 12:329-40. 10.1007\/s003300101037","journal-title":"Eur Radiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.57.3.393","article-title":"MRI features of primary central nervous system lymphomas at presentation","volume":"57","author":"B\u00fchring U","year":"2001","unstructured":"B\u00fchring U, Herrlinger U, Krings T, Thiex R, Weller M, K\u00fcker W. MRI features of primary central nervous system lymphomas at presentation. Neurology. 2001, 57:393-6. 10.1212\/wnl.57.3.393","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21366","article-title":"Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma","volume":"63","author":"Porter AB","year":"2008","unstructured":"Porter AB, Giannini C, Kaufmann T, et al.. Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma. Ann Neurol. 2008, 63:662-7. 10.1002\/ana.21366","journal-title":"Ann Neurol"},{"key":"ref22","article-title":"MR of primary CNS lymphoma in immunologically normal patients","volume":"13","author":"Roman-Goldstein SM","year":"1992","unstructured":"Roman-Goldstein SM, Goldman DL, Howieson J, Belkin R, Neuwelt EA. MR of primary CNS lymphoma in immunologically normal patients. AJNR Am J Neuroradiol. 1992, 13:1207-13.","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2171","article-title":"Central nervous system lymphoma: characteristic findings on traditional and advanced imaging","volume":"32","author":"Haldorsen IS","year":"2011","unstructured":"Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol. 2011, 32:984-92. 10.3174\/ajnr.A2171","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1148\/radiographics.17.6.9397461","article-title":"Primary central nervous system lymphoma: radiologic-pathologic correlation","volume":"17","author":"Koeller KK","year":"1997","unstructured":"Koeller KK, Smirniotopoulos JG, Jones RV. Primary central nervous system lymphoma: radiologic-pathologic correlation. Radiographics. 1997, 17:1497-526. 10.1148\/radiographics.17.6.9397461","journal-title":"Radiographics"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab020","article-title":"Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)","volume":"23","author":"Barajas RF","year":"2021","unstructured":"Barajas RF, Politi LS, Anzalone N, et al.. Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG). Neuro Oncol. 2021, 23:1056-71. 10.1093\/neuonc\/noab020","journal-title":"Neuro Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2005.05.009","article-title":"Clinical features and diagnosis of primary central nervous system lymphoma","volume":"19","author":"Fitzsimmons A","year":"2005","unstructured":"Fitzsimmons A, Upchurch K, Batchelor T. Clinical features and diagnosis of primary central nervous system lymphoma. Hematol Oncol Clin North Am. 2005, 19:689-703, vii. 10.1016\/j.hoc.2005.05.009","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref27","article-title":"Corticosteroid pre-treated primary CNS lymphoma: a detailed analysis of stereotactic biopsy findings and consideration of interobserver variability","volume":"8","author":"\u00d6nder E","year":"2015","unstructured":"\u00d6nder E, Ar\u0131k\u00f6k AT, \u00d6nder S, et al.. Corticosteroid pre-treated primary CNS lymphoma: a detailed analysis of stereotactic biopsy findings and consideration of interobserver variability. Int J Clin Exp Pathol. 2015, 8:7798-808.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.03.080","article-title":"The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients","volume":"61","author":"Nguyen-Them L","year":"2016","unstructured":"Nguyen-Them L, Costopoulos M, Tanguy ML, et al.. The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients. Eur J Cancer. 2016, 61:69-76. 10.1016\/j.ejca.2016.03.080","journal-title":"Eur J Cancer"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-014-1622-z","article-title":"Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system","volume":"121","author":"Sasagawa Y","year":"2015","unstructured":"Sasagawa Y, Akai T, Tachibana O, Iizuka H. Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system. J Neurooncol. 2015, 121:177-83. 10.1007\/s11060-014-1622-z","journal-title":"J Neurooncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4450","article-title":"The combined performance of ADC, CSF CXC chemokine ligand 13, and CSF interleukin 10 in the diagnosis of central nervous system lymphoma","volume":"37","author":"Mabray MC","year":"2016","unstructured":"Mabray MC, Barajas RF, Villanueva-Meyer JE, Zhang CA, Valles FE, Rubenstein JL, Cha S. The combined performance of ADC, CSF CXC chemokine ligand 13, and CSF interleukin 10 in the diagnosis of central nervous system lymphoma. AJNR Am J Neuroradiol. 2016, 37:74-9. 10.3174\/ajnr.A4450","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/srep38671","article-title":"Cerebrospinal fluid IL-10 and IL-10\/IL-6 as accurate diagnostic biomarkers for primary central nervous system large B-cell lymphoma","volume":"6","author":"Song Y","year":"2016","unstructured":"Song Y, Zhang W, Zhang L, et al.. Cerebrospinal fluid IL-10 and IL-10\/IL-6 as accurate diagnostic biomarkers for primary central nervous system large B-cell lymphoma. Sci Rep. 2016, 6:38671. 10.1038\/srep38671","journal-title":"Sci Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S255482","article-title":"High level of IL-10 in cerebrospinal fluid is specific for diagnosis of primary central nervous system lymphoma","volume":"12","author":"Shao J","year":"2020","unstructured":"Shao J, Chen K, Li Q, et al.. High level of IL-10 in cerebrospinal fluid is specific for diagnosis of primary central nervous system lymphoma. Cancer Manag Res. 2020, 12:6261-8. 10.2147\/CMAR.S255482","journal-title":"Cancer Manag Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/376354-diagnostic-performance-of-csf-interleukin-10-in-primary-central-nervous-system-lymphoma-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:02Z","timestamp":1753890902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/376354-diagnostic-performance-of-csf-interleukin-10-in-primary-central-nervous-system-lymphoma-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.89063","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,30]]}}}